The China Shanghai Composite Index experienced a notable decline, falling by 2.06% today. Over the past five days, the index has decreased by 1.44%, and it has seen a more significant drop of 2.92% over the last 30 days, reflecting ongoing market challenges. In terms of market performance, the advance-decline ratio indicates a significant imbalance, with 713 stocks advancing compared to 4,235 stocks declining, resulting in an overall ratio of 0.17. Large-cap stocks showed a similar trend, with 289 advancing against 1,011 declining, yielding a ratio of 0.29. Mid-cap stocks also faced pressure, with 172 advancing and 986 declining, while small-cap stocks struggled the most, with only 184 advancing versus 1,698 declining, leading to a ratio of 0.11. Among the notable performers, Arcplus Group Plc led large-cap stocks with a return of 10.04%, while Shannon Semiconductor Technology Co. Ltd. faced the steepest decline at -20.0%. In the mid-cap sector, Shanghai Kaibao Pharmaceutical Co., Ltd. achieved a return of 15.81%, while Chengdu Olymvax Biopharmaceuticals, Inc. dropped by 19.56%. Small-cap stocks saw Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. rise by 20.0%, while J.Pond Precision Technology Co., Ltd. fell by 20.0%.